Repare Therapeutics Investor Relations Material
Latest events
Study Update
Repare Therapeutics
Q1 2025
4 Jun, 2025
Q4 2024
3 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Repare Therapeutics Inc
Access all reports
Repare Therapeutics Inc. (RPTX) is a clinical-stage precision oncology company focused on the development of novel therapeutics using its synthetic lethality approach. The company leverages its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies aimed at genomic instability, including DNA damage repair.
Key slides for Repare Therapeutics Inc
Study Update
Repare Therapeutics Inc
Study Update
Repare Therapeutics Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
RPTX
Country
🇺🇸 United States